FDA approves generic valsartan amid drug shortage
(Reuters) – The U.S. Food and Drug Administration said on Tuesday it had approved a new generic version of blood pressure medicine valsartan, as the agency looks to ease shortages…
Appeals court says Ohio may withhold Planned Parenthood funding
(Reuters) – A divided federal appeals court on Tuesday rejected Planned Parenthood’s constitutional challenge to an Ohio law depriving the organization of state funding because it performs abortions, handing a…
FDA approves Pfizer’s biosimilar to Roche’s Herceptin
FILE PHOTO: The logo of U.S. pharmaceutical corporation Pfizer Inc. is seen at a branch in Zurich, Switzerland October 2, 2018. REUTERS/Arnd Wiegmann (Reuters) – The U.S. Food and Drug…
Kids with asthma may struggle in school
(Reuters Health) – Kids with asthma may struggle more in school when their symptoms aren’t well-controlled, and minority students with this breathing disorder are more likely to fall behind than…
Seniors increasingly breaking bones while walking dogs
(Reuters Health) – Older adults who walk their dogs on a leash have been breaking bones at an increasing rate, with women and hip bones most at risk, researchers say.…
Long-term obesity tied to higher dementia risk in healthy older adults
(Reuters Health) – Healthy older adults who have been obese for years may be at higher risk of developing dementia than their peers who aren’t overweight, research from the UK…
Knee surgery for torn cartilage may not be worthwhile
(Reuters Health) – Many middle-aged and older adults with torn cartilage and pain in their knee are not likely to benefit from so-called arthroscopic surgery, a review of past studies…
Women who vape around pregnancy may wrongly think it safe
(Reuters Health) – Health professionals advise against using any nicotine products during pregnancy, but some women are using e-cigarettes before, during or after pregnancy and thinking it’s safer than smoking,…
J&J nasal spray gets U.S. approval as first new type of anti-depressant in decades
(Reuters) – The U.S. Food and Drug Administration on Tuesday said it approved a Johnson & Johnson nasal spray antidepressant for people resistant to other treatments but placed restrictions on…
Allergan’s add-on treatment for depression fails late-stage studies
FILE PHOTO: The Allergan logo is seen in this photo illustration November 23, 2015. To match special report USA-FDA/CASES REUTERS/Thomas White/Illustration/File Photo (Reuters) – Allergan Plc said on Wednesday its…